Black Opal Ventures

Black Opal Ventures (BOV) is a New York-based venture capital firm co-founded in 2021 by Dr. Tara Bishop and Eileen Tanghal, both MIT alumni. The firm invests in early-stage companies at the intersection of healthcare and technology, with sector focus spanning healthtech, tech bio, cybersecurity, infrastructure, and semiconductors. Its inaugural fund (Fund I) had its first closing in February 2022 and had raised approximately $58–63M as of late 2023, with limited partners including Eli Lilly, Bank of America, J.P. Morgan Asset Management's Project Spark, Henry Ford Health, and Illumen Capital. BOV targets Seed through Series B companies primarily based in the United States, with some international portfolio exposure. In addition to capital, the firm runs a Black Opal Venture Fellows Program — a three-month fellowship focused on healthcare and technology that offers participants a $1,000/month stipend and engagement in the investment process. Deal submissions can be made directly via the firm's website contact form.